In a follow up to Episode 35, we continue our series looking at an industry-leading study customers from our brands, Hemp Bombs and Nature’s Script, are taking part in looking at the effects CBD has on liver health. Patrick McCarthy, CEO of ValidCare, the company behind the study, discusses the objectives of the study, how consumers were chosen to take part, what the objectives of the study are and how the CBD brands taking part are providing critical information that will be used to send data to the FDA following the study.